Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2018, Cardeon AB is a Sweden-based investment company focused on the Nordic region. The firm specializes in medical technology and life sciences, with its shares listed on NGM Nordic SME since November 2022. Cardeon manages a portfolio of five companies, leveraging its expertise to support startups from research to commercialization.
Cardeon invests in innovative companies within the biotech and healthcare sectors, aiming for significant global market impact. The firm provides funding, financing strategies, and access to a broad network to facilitate collaborations and assist in key recruitments. Investments are directed towards companies that can transform their respective markets.
Notable portfolio companies include Prolight Diagnostics, which develops diagnostic solutions; SpectraCure, focused on cancer treatment technologies; Deep Light Vision, working on advanced imaging solutions; TEQCool, which develops cooling technologies for medical applications; and AcroPharma, involved in pharmaceutical innovations.
Submit your pitch through their form at cardeon.se.
Cardeon typically participates in funding rounds but may lead depending on the opportunity and alignment with their investment strategy.
The firm is open to follow-on investments in portfolio companies that demonstrate growth potential and alignment with their strategic goals.
Specific details about the fund size are not disclosed, but Cardeon focuses on providing substantial support to its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.